Age-dependent changes on TGFβ1 Smad3 pathway modify the pattern of microglial cell activation

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Aging is a primary risk factor for Alzheimer's disease, associated with altered inflammatory signaling and glial cell activation.
• Astrocytes normally use TGFβ1 to protect against microglial cytotoxicity, but this protective mechanism appears compromised in aging.
• Despite increased TGFβ1 in aging, glial cell activation persists, creating a paradox that requires investigation.

Purpose of the Study:

• To investigate the TGFβ1-Smad3 signaling pathway during aging and its impact on microglial cell function.
• To understand how age-related changes in this pathway affect microglial responses to inflammation, including nitric oxide and reactive oxygen species production, and phagocytosis.

Main Methods:

• Studied TGFβ1-Smad3 signaling in the hippocampus of young and adult mice following inflammatory stimulation (LPS).
• Assessed nitric oxide (NO) and reactive oxygen species (ROS) secretion by microglia from different age groups with and without LPS treatment.
• Evaluated microglial phagocytosis in response to inflammation and TGFβ1, with and without Smad3 inhibition.

Main Results:

• TGFβ1 induction and Smad3 activation were significantly reduced in adult mice upon inflammatory stimulation.
• LPS induced NO secretion primarily in young microglia, while adult microglia predominantly produced ROS.
• TGFβ1 modulated NO/ROS production differently in young and adult microglia, with Smad3 pathway involvement being impaired in aging and by inflammatory preconditioning.
• Microglial phagocytosis was induced by inflammation and TGFβ1 only in young mice, and this induction was blocked by Smad3 inhibition.

Conclusions:

• Activation of the TGFβ1-Smad3 pathway is impaired during aging.
• Age-related deficits in TGFβ1-Smad3 signaling can diminish protective microglial functions and promote cytotoxic activation.
• This impairment may contribute to microglia-mediated neurodegeneration in aging and Alzheimer's disease.